DiaMedica Therapeutics (DMAC) Form 3 DiaMedica Therapeutics / AB TomEnterprise ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Von Koch Thomas

(Last) (First) (Middle)

C/O EQT PARTNERS AB

BOX 16509

(Street)

STOKCHOLM V7 103 27

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/08/2022

3. Issuer Name and Ticker or Trading Symbol
DiaMedica Therapeutics Inc. [ DMAC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	2,647,873	I	See Footnote(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Von Koch Thomas

(Last) (First) (Middle)

C/O EQT PARTNERS AB

BOX 16509

(Street)

STOKCHOLM V7 103 27

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

TomEnterprise AB

(Last) (First) (Middle)

C/O EQT PARTNERS AB

BOX 16509

(Street)

STOCKHOLM V7 103 27

(City) (State) (Zip)

Explanation of Responses:

1. These shares are owned directly by TomEnterprise AB and indirectly by Thomas Von Koch in his capacity as the board member and sole owner of TomEnterprise AB. Thomas Von Koch has the sole power to vote and dispose of these shares.

	/s/ Thomas Von Koch	07/21/2022
	/s/ Thomas Von Koch, as Board Member of TomEnterprise AB	07/21/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.